# Migraine Headaches: A Comprehensive Patient Guide **Prepared by:** Pedro Cheung MD **Last Updated:** May 2026 **Prepared for patient education purposes. This handout does not replace the advice of your healthcare provider.** --- ## What Is a Migraine? A migraine is far more than a bad headache. It is a complex neurological disorder that typically causes moderate to severe throbbing or pulsating head pain, often on one side of the head. Migraines are frequently accompanied by nausea, vomiting, and intense sensitivity to light (photophobia) and sound (phonophobia). In some people, migraines begin with warning symptoms called **aura** — visual disturbances (such as zigzag lines or blind spots), numbness, tingling, or speech changes that usually appear 20–60 minutes before the headache. Migraine is the **second leading cause of disability** worldwide, and it significantly affects quality of life, work productivity, and relationships. --- ## How Common Are Migraines? - Migraines affect approximately **15% of the global population** — over 1 billion people. - Women are **2–3 times more likely** to experience migraines than men, largely due to the influence of sex hormones (particularly estrogen). - Migraines typically begin during puberty and peak during the reproductive years (ages 25–55). - First-degree relatives of people with migraines have a **4 times greater risk** of also developing migraines with aura.¹ --- ## The Four Phases of a Migraine Attack ### 1. Premonitory (Prodrome) Phase — Hours to Days Before Many people notice subtle warning signs 6–48 hours before pain begins: - Fatigue, yawning - Neck stiffness - Mood changes (irritability, depression, or unusual elation) - Food cravings - Increased sensitivity to light or sound ### 2. Aura Phase (in ~25–30% of migraines) Visual or sensory changes that last 5–60 minutes, then resolve: - Visual disturbances (zigzag lines, flashing lights, blind spots) - Numbness or tingling (usually face, arm, or hand) - Difficulty speaking ### 3. Headache Phase — 4 to 72 Hours - Moderate to severe pain, usually one-sided - Throbbing or pulsating quality - Worsened by routine physical activity - Nausea and/or vomiting - Sensitivity to light, sound, and sometimes smell ### 4. Postdrome ("Migraine Hangover") — 24–48 Hours After - Fatigue, brain fog, difficulty concentrating - Residual sensitivity to light or sound - Feeling "washed out" or unusually refreshed --- ## What Causes Migraines? The Science of Migraine Pain Modern research has fundamentally shifted our understanding of migraines from a simple vascular ("blood vessel") problem to a complex **neurovascular** disorder — one involving both the nervous system and blood vessels acting together. ### Cortical Spreading Depression (CSD): The Brain Wave Behind Aura In people who experience migraine with aura, a slow-moving wave of electrical activity called **cortical spreading depression (CSD)** passes across the surface of the brain at 2–6 mm per minute. This wave causes neurons and glial cells to suddenly depolarize (fire electrically), followed by a period of silence — which is what produces aura symptoms.² CSD involves a rapid rise in extracellular potassium, intracellular sodium and calcium, and elevated glutamate (an excitatory brain chemical). Once this wave passes, it activates the trigeminal pain pathway and triggers the headache.² Importantly, CSD appears to play a role primarily in **migraine with aura**; migraine without aura likely depends more directly on other neurogenic mechanisms without CSD initiation.² ### The Trigeminovascular System: The Pain Pathway The headache itself arises when the trigeminal nerve — the large sensory nerve serving the face and head — is activated and sensitized. Trigeminal nerve fibers wrap around blood vessels in the meninges (the membranes surrounding the brain). When these fibers are activated, they release **inflammatory neuropeptides** that cause: - Vasodilation of meningeal blood vessels - Neurogenic inflammation in the dura mater - Sensitization of meningeal pain receptors (nociceptors) This pain signal travels from peripheral nerves into the trigeminal nucleus in the brain stem, then up to the thalamus and cortex, where it is experienced as migraine headache pain.³ ### CGRP: The Key Pain Molecule **Calcitonin gene-related peptide (CGRP)** is a 37-amino acid neuropeptide that has emerged as the most important molecular target in migraine science and treatment. During a migraine attack, CGRP is **markedly elevated** in the blood.⁴ CGRP is released from trigeminal nerve endings and: - Causes potent vasodilation of cerebral and meningeal blood vessels - Amplifies pain signals at the trigeminal ganglion - Sensitizes meningeal nociceptors - May contribute to allodynia (pain from non-painful stimuli, like brushing hair) CGRP also appears to contribute to the greater migraine prevalence in women, as estrogen receptors in the trigeminal ganglion amplify CGRP expression.² This discovery led to an entire new class of highly effective migraine medications specifically targeting CGRP and its receptor (gepants and CGRP monoclonal antibodies). ### Serotonin's Role Serotonin (5-hydroxytryptamine, or 5-HT) is also important. During a migraine, serotonin levels fluctuate, and the serotonin receptors 5-HT1B and 5-HT1D play a key role in pain signaling within the trigeminovascular system. When activated by serotonin or serotonin-like drugs (triptans), these receptors cause vasoconstriction and inhibit nociceptive neuropeptide release, which is why triptans relieve migraine pain.² ### Other Contributing Factors - **Low magnesium** in the brain lowers the threshold for neuronal excitability, promotes glutamate release, and may trigger CSD.² - **PACAP-38** (pituitary adenylate cyclase-activating peptide) is an emerging neuropeptide that can trigger vasodilation and migraine-like attacks; it is a future therapeutic target.² - **Glial cells** (astrocytes and microglia) contribute to the neuroinflammatory environment that sustains migraine chronification.² - **Genetics**: A strong hereditary component exists — first-degree relatives of aura migraineurs have ~4x the risk; multiple genes including those affecting ion channels, serotonin transporters, and estrogen receptors are implicated.² --- ## Common Migraine Triggers **Important note:** Triggers are highly individual and complex. Modern research from a large 1,125-person prospective cohort study found that many commonly cited "triggers" actually **protected** some individuals from migraine attacks rather than provoking them — particularly caffeine, alcohol, sleep, and physical activity.⁵ The current recommendation leans toward understanding and coping with triggers rather than rigidly avoiding everything. ### Common Triggers Include: **Behavioral/Lifestyle:** - Irregular sleep schedules (too much or too little sleep) - Skipping or delaying meals - Dehydration - Stress and emotional upset - Intense physical exertion - Changes in routine **Environmental:** - Bright or flickering lights - Strong odors - Weather changes, high altitude, barometric pressure changes - Loud noises **Hormonal (Women):** - Perimenstrual period (2 days before to 3 days after menstruation) - Oral contraceptives - Pregnancy (usually worsens in first trimester; often improves in second) - Perimenopause and menopause (estrogen fluctuation) **Dietary:** - Alcohol (especially red wine) - Caffeine (both overuse and withdrawal) - Aged cheeses, cured meats (tyramine content) - Additives (MSG, artificial sweeteners in some individuals) - Fasting or low blood sugar **Medical:** - Poor posture, neck or jaw tension - Sleep disorders (insomnia, sleep apnea) - Anxiety and depression --- ## Lifestyle Changes That Help Prevent Migraines The American Headache Society (AHS) Consensus Statement emphasizes that **lifestyle modification is a cornerstone** of any migraine management plan and should be initiated before or alongside medication.⁶ ### Regular, Consistent Sleep Sleep disturbance is both a trigger and a risk factor for migraine chronification. Maintaining consistent sleep and wake times — even on weekends — reduces migraine frequency. Sleep disorders (insomnia, sleep apnea, restless legs) should be identified and treated.⁷ **Recommended: 7–9 hours per night on a consistent schedule.** ### Adequate Hydration Dehydration is a well-recognized migraine trigger. A prospective cohort study found adequate hydration showed a protective effect on migraine onset.⁵ **Recommended: Drink at least 8–10 glasses of water daily, reducing caffeinated beverages.** ### Regular Meals — Don't Skip Skipping meals causes drops in blood sugar that can trigger migraine. Regular meal timing was associated with reduced attack risk.⁵ **Recommended: Eat regular meals at consistent times; don't skip breakfast.** ### Regular Aerobic Exercise Exercise is one of the most evidence-based lifestyle interventions for migraine prevention. A meta-analysis found that **yoga, high-intensity aerobic exercise, and moderate-intensity continuous aerobic exercise** were superior to pharmacological treatment alone for reducing migraine frequency. Yoga was the only exercise type shown to also reduce migraine intensity. High- and moderate-intensity aerobic exercise reduced migraine duration.⁸ **Recommended: At least 150 minutes of moderate aerobic activity per week; exercise at consistent times, ideally in the morning, combined with adequate hydration and regular sleep.** ### Stress Management Stress is among the most commonly reported migraine triggers. Mind-body approaches with Grade A evidence for migraine prevention include:⁹ - **Cognitive Behavioral Therapy (CBT)** — helps restructure negative thought patterns and develop coping skills - **Biofeedback** (particularly thermal and EMG biofeedback) — patients learn to control physiological responses linked to migraine - **Relaxation training** — progressive muscle relaxation, guided imagery - **Mindfulness-based therapies** — mindfulness meditation, mindfulness-based stress reduction (MBSR) These non-drug therapies are especially appropriate for patients who prefer to avoid or minimize medications, are pregnant, or have a history of medication overuse.⁹ ### Caffeine — A Double-Edged Sword Moderate caffeine can relieve mild migraines (and is included in some OTC migraine medications). However, **caffeine overuse (>100–200 mg/day) is a risk factor for medication overuse headache**, and caffeine withdrawal is a potent migraine trigger. Gradually reduce caffeinated beverages if consuming more than 1–2 cups of coffee daily. ### Maintain a Healthy Weight Obesity (BMI ≥30) is a risk factor for migraine chronification (episodic migraine transforming into chronic migraine, defined as ≥15 headache days/month). Weight loss through healthy diet and exercise can reduce migraine frequency. --- ## Medications for Migraine: Stopping an Attack **Key Principle:** Treat migraines **early** — at the first sign of pain, before it escalates. Non-oral routes (nasal spray, injection) work faster when nausea is present. ### Step 1: Over-the-Counter Medications (Mild to Moderate Migraines) - **NSAIDs:** Ibuprofen (400–800 mg), naproxen sodium (500 mg), or aspirin (1,000 mg) — most effective when taken early. Often more effective than acetaminophen alone. - **Acetaminophen (Tylenol):** 1,000 mg — may help mild attacks. - **Excedrin Migraine (OTC combination):** Contains aspirin + acetaminophen + caffeine — effective for mild to moderate migraine. - **⚠️ Caution:** Using any OTC pain reliever more than 10–15 days per month risks triggering **medication overuse headache** (see below). ### Step 2: Prescription Triptans (Moderate to Severe Migraines) Triptans are the most effective prescription medications for stopping a migraine attack. They work by activating serotonin receptors (5-HT1B/1D) to reverse vasodilation and inhibit pain signaling in the trigeminal system.² |Triptan|Available Forms|Notes| |---|---|---| |Sumatriptan (Imitrex)|Tablet, injection, nasal spray|Most studied; injection fastest onset| |Rizatriptan (Maxalt)|Tablet, dissolving tablet|Fast acting| |Zolmitriptan (Zomig)|Tablet, nasal spray|Nasal spray useful with nausea| |Eletriptan (Relpax)|Tablet|Effective; longer duration| |Naratriptan (Amerge)|Tablet|Slower onset; less rebound| |Frovatriptan (Frova)|Tablet|Long half-life; good for menstrual migraine| |Almotriptan (Axert)|Tablet|Fewer side effects for some| **Possible side effects:** Chest tightness, flushing, tingling, dizziness, fatigue. **Contraindications:** Heart disease, history of stroke, uncontrolled high blood pressure, certain vascular conditions. Always discuss with your doctor. **⚠️ Rebound risk:** Using triptans more than **10 days per month** significantly increases risk of medication overuse headache. The triptan discontinuation rate is 50–82% due to side effects or loss of efficacy.² ### Step 3: Newer Targeted Acute Medications **Ditans (5-HT1F Agonists) — No Vasoconstriction** - **Lasmiditan (Reyvow):** Selectively targets 5-HT1F receptors — blocks CGRP and glutamate release without the vasoconstriction of triptans. **Safe for patients with cardiovascular disease** who cannot take triptans.² - Side effects: Dizziness, sedation (do not drive for 8 hours after taking). **Gepants (CGRP Receptor Antagonists) — Dual Acute + Preventive** Gepants directly block the CGRP receptor (CLR/RAMP1 heterodimer), stopping the migraine mechanism at its source.² |Gepant|Use|Notes| |---|---|---| |Ubrogepant (Ubrelvy)|Acute treatment|Taken at onset; can take 2nd dose if needed| |Rimegepant (Nurtec ODT)|Acute AND preventive|Dissolving tablet; also used every other day for prevention| |Zavegepant (Zavzpret)|Acute treatment|Nasal spray; fastest onset of gepants| **Key advantage of gepants:** Clinical evidence to date does **not** show gepants cause medication overuse headache — a major benefit over triptans and traditional analgesics. They are also now being used therapeutically to help patients **break** the MOH cycle when transitioning off overused medications. --- ## Medications for Migraine Prevention **Who needs preventive treatment?** Consider preventive therapy if you have: - **4 or more migraine days per month** - Migraines causing significant disability - Acute medications that are inadequate, poorly tolerated, or contraindicated - Risk of medication overuse headache The goal of preventive medication is to reduce migraine frequency by at least 50%. ### CGRP Monoclonal Antibodies (mAbs) — Newest and Most Targeted These injectable or IV medications specifically target CGRP or its receptor and represent the **first migraine-specific preventive treatments** ever developed. |Medication|Type|Administration|Dosing| |---|---|---|---| |Erenumab (Aimovig)|CGRP receptor blocker|Subcutaneous injection|Monthly| |Galcanezumab (Emgality)|Anti-CGRP antibody|Subcutaneous injection|Monthly| |Fremanezumab (Ajovy)|Anti-CGRP antibody|Subcutaneous injection|Monthly or quarterly| |Eptinezumab (Vyepti)|Anti-CGRP antibody|IV infusion|Quarterly| **Advantages:** Minimal systemic side effects, no need for daily dosing, no drug interactions, no titration, rapid onset (often within weeks), and **no evidence of medication overuse headache**. Many patients who failed multiple older preventives respond well to these agents. **Side effects:** Injection site reactions, mild constipation with erenumab in some patients. ### Traditional Oral Preventive Medications These older medications are effective and widely used, though they require daily dosing and titration and may have more side effects: |Medication|Category|Common Dose Range|Notable Side Effects| |---|---|---|---| |Propranolol (Inderal)|Beta-blocker|80–240 mg/day|Fatigue, cold extremities; avoid in asthma| |Metoprolol (Lopressor)|Beta-blocker|100–200 mg/day|Fatigue, bradycardia| |Amitriptyline (Elavil)|Tricyclic antidepressant|10–75 mg at bedtime|Drowsiness, dry mouth, weight gain| |Topiramate (Topamax)|Antiepileptic|50–100 mg/day|Cognitive dulling ("Dopamax"), tingling, weight loss| |Valproate/Valproic acid|Antiepileptic|500–1,000 mg/day|Weight gain, hair loss; **avoid in pregnancy**| |Venlafaxine (Effexor)|SNRI antidepressant|75–150 mg/day|Nausea, insomnia| **Note:** Gabapentin is **no longer recommended** for migraine prevention per the 2023 VA/DoD Clinical Practice Guidelines due to insufficient evidence. ### OnabotulinumtoxinA (Botox) — For Chronic Migraine For patients with **chronic migraine (≥15 headache days/month)**, Botox injections into 31 head and neck sites every 12 weeks is FDA-approved and effective. Works by blocking release of pain-promoting neurotransmitters from trigeminal nerve endings. ### Oral CGRP Antagonists for Prevention - **Atogepant (Qulipta):** Daily oral gepant; FDA-approved for preventive treatment of both episodic and chronic migraine. - **Rimegepant (Nurtec):** Every-other-day dosing; FDA-approved for both acute and preventive use. --- ## ⚠️ Rebound Headaches: Medication Overuse Headache (MOH) **Medication overuse headache (MOH) — formerly called "rebound headache" — is one of the most common and underrecognized headache problems worldwide, affecting more than 60 million people globally.**¹⁰ ### What Is MOH? MOH is defined (per ICHD-3 criteria) as headache occurring **15 or more days per month** in someone with a pre-existing headache disorder, caused by **regular overuse** of acute headache medications for **more than 3 months**.¹⁰ The medications most commonly involved and their overuse thresholds are: |Medication Class|Days/Month Threshold That Causes MOH| |---|---| |Triptans|**≥10 days/month**| |Ergotamines|≥10 days/month| |Opioids (narcotics)|≥10 days/month| |Simple analgesics (aspirin, ibuprofen, acetaminophen alone)|≥15 days/month| |Combination analgesics (Excedrin, products with caffeine/butalbital)|≥10 days/month| |**Gepants (ubrogepant, rimegepant)**|**Appear NOT to cause MOH** — currently a key clinical advantage| ### How MOH Develops When acute pain medications are used too frequently, the brain adapts by becoming increasingly sensitive to pain signals. The very medication being used to treat headache begins to lower the threshold for headache to occur. The result is a vicious cycle: more frequent headaches → more medication → even more frequent headaches. ### Warning Signs of MOH - Headaches occurring more than 15 days per month - Headaches that are present most mornings when you wake up - Headaches that start improving only after taking pain medication - Needing increasing amounts of medication to get relief - Previously effective medications becoming less effective ### How to Break the MOH Cycle Treatment requires **stopping the overused medication** — this is called medication withdrawal. Your healthcare provider will discuss: **Withdrawal approach:** Abrupt discontinuation works for most medications. Opioids and barbiturates (e.g., butalbital) may require a gradual taper. **What to expect:** Withdrawal headaches typically worsen initially for several days before improving. This is normal and expected. The "detox" period usually lasts 2–10 days. **Concurrent preventive therapy:** Starting a preventive medication at the same time as withdrawal significantly improves outcomes. In clinical trials, patients who began preventive therapy at the time of withdrawal had: - 74.2% reversion back to episodic migraine - 96.8% had no evidence of MOH at follow-up¹⁰ **Bridge therapies** your doctor may use to ease withdrawal include nasal or IV dihydroergotamine, corticosteroids, or IV valproate. **Key message:** MOH is reversible. Most patients see significant headache improvement within 1–3 months of stopping the overused medication. --- ## Traditional Chinese Medicine (TCM) Approaches ### Acupuncture — The Most Evidence-Supported TCM Approach Acupuncture is the most rigorously studied TCM intervention for migraine and has gained substantial recognition in Western medicine. **What the evidence shows:** A 2020 overview of 15 systematic reviews on acupuncture for migraine (Li et al., _Pain Research and Management_) found high-quality evidence that:¹¹ - The **effective rate** of acupuncture was superior to Western medicine (risk ratio = 1.17; 95% CI: 1.12–1.22) - Acupuncture reduced **more headache days** (SMD = −0.13) and **reduced painkiller use** compared to Western medicine and sham acupuncture - Acupuncture was more effective in reducing **headache frequency** (SMD = −2.18) and **pain severity** (SMD = −1.93) than controls A separate systematic review (Zhang et al., _Headache_, 2020) of 7 RCTs comparing acupuncture to standard pharmacological prevention found **"growing evidence that acupuncture is just as effective and has fewer side effects"** than many standard pharmaceutical agents.¹² **Important caveats:** - Most underlying trials are of **critically low methodological quality** per AMSTAR-2 assessment¹¹ - The distinction between **true acupuncture and sham acupuncture** remains debated: some meta-analyses show no statistically significant difference in migraine day reduction between true and sham needling, suggesting some effects may arise from the ritual of needling, enhanced therapeutic relationship, or unknown biological mechanisms of needle insertion at any point - Despite this, acupuncture compares **non-inferiorly to conventional preventive drugs** in most trials — and with fewer side effects **Practical recommendation:** Acupuncture is a reasonable, evidence-supported option for migraine prevention, particularly for patients who prefer non-pharmacological treatment, cannot tolerate medications, or are pregnant. AHS consensus supports it as an appropriate complementary or alternative treatment.⁹ **TCM mechanism:** Acupuncture may modulate nitric oxide synthase activity, 5-HT1F receptor expression, CGRP release, and descending pain modulation pathways.¹² **Typical approach:** 6–12 sessions over 6–12 weeks is commonly studied; evidence supports continuation for ongoing prevention. ### Other TCM Modalities **Herbal medicine:** Several Chinese herbal preparations have been studied for migraine. One systematic review (Zhang et al., 2019) noted that acupuncture showed superior efficacy to Chinese herbal medicine in treating migraine (RR = 1.29, 95% CI: 1.14–1.45).¹¹ The most commonly studied herbs include: - **Tian ma (Gastrodia elata):** Used for headache in TCM; animal studies suggest antinociceptive effects, but human RCT evidence remains limited - **Chuan xiong (Ligusticum chuanxiong):** Contains tetramethylpyrazine; may inhibit vasospasm; used in headache formulas **Important:** Chinese herbal preparations vary considerably in composition and quality. Always inform your doctor before using herbal remedies, as interactions with medications are possible. **Moxibustion and cupping:** Traditional practices sometimes used alongside acupuncture for headache management. Evidence specifically for migraine is much more limited than for acupuncture. --- ## Supplements and Nutraceuticals The American Academy of Neurology (AAN) and American Headache Society (AHS) have evaluated several supplements for migraine prevention. These are **not regulated by the FDA** for migraine treatment, so quality varies by brand. Discuss with your healthcare provider before starting any supplement. ### Magnesium — Level B Evidence (Probably Effective) **Why it works:** Magnesium levels in the brain are **lower than normal** in many migraine patients. Magnesium inhibits calcium influx into neurons, reduces glutamate release, and may also inhibit CGRP and serotonin release — addressing multiple pathways in migraine pathophysiology.² Magnesium deficiency may lower the threshold for CSD.² **Dosing:** 400–600 mg of magnesium oxide or magnesium citrate per day (citrate is better absorbed). **Evidence:** Multiple RCTs and the AAN/AHS guidelines support magnesium supplementation for both prevention (oral) and acute treatment (intravenous magnesium in emergency settings).¹³ **Side effects:** Diarrhea and gastrointestinal discomfort (the main reason patients discontinue); start with a lower dose and increase gradually. **Safety:** Generally very safe; caution in kidney disease. ### Riboflavin (Vitamin B2) — Level B Evidence (Probably Effective) **Why it works:** Migraineurs may have impaired mitochondrial energy metabolism. Riboflavin enhances mitochondrial function and helps restore energy balance in brain cells. **Dosing:** 400 mg per day. **Evidence:** Level B evidence (probably effective) per AAN/AHS guidelines for **adult migraine prevention**. Pediatric evidence is less established.¹³ Well tolerated; may turn urine bright yellow — harmless. **Side effects:** Minimal. Safe for long-term use. ### Coenzyme Q10 (CoQ10) — Level C Evidence (Possibly Effective) **Why it works:** CoQ10 supports mitochondrial energy production and reduces inflammatory markers. Studies show CoQ10 lowers TNF-α and CGRP levels — key mediators of migraine.¹³ **Dosing:** 100–300 mg per day (bioavailability varies significantly by formulation; ubiquinol form may be better absorbed). **Evidence:** A meta-analysis of 6 small RCTs found CoQ10 reduced headache frequency (~1.5 fewer attacks per month) and headache duration. Effect on severity was less consistent.¹³ Level C evidence (possibly effective) per AAN/AHS. **Side effects:** Generally minimal; occasional mild GI upset. ### Feverfew — Level B Evidence (Probably Effective, with Caveats) **Why it works:** The active ingredient **parthenolide** partially desensitizes the TRPA1 ion channel, reducing CGRP release and meningeal vasodilation in preclinical studies.² Feverfew also shows antiplatelet activity by suppressing thromboxane synthesis.¹⁴ **Dosing:** Typically 50–150 mg/day of standardized extract (0.2–0.7% parthenolide). **Evidence:** Level B evidence per AAN/AHS, but clinical trial results have been inconsistent — several trials have failed to replicate positive results, likely due to variations in dosing, preparation type, and trial design.¹³ **Cautions:** - **Not recommended during pregnancy** (may stimulate uterine contractions) - Avoid in patients taking blood thinners (anticoagulants/antiplatelet drugs) due to antiplatelet activity - Abrupt discontinuation after prolonged use may cause "post-feverfew syndrome" (rebound headache, muscle aches) - Standardization varies widely between products ### Butterbur (Petasites hybridus) — ⚠️ CAUTION: Guideline Retracted **Historical context:** Butterbur was previously classified as **Level A evidence** (strongest evidence) by the 2012 AAN/AHS guidelines for migraine prevention, with a dose of 75 mg twice daily reducing migraine frequency by 48% vs. 26% for placebo. **However:** In **2015, the AAN formally retired and retracted** its butterbur recommendation due to **serious safety concerns** regarding hepatotoxicity (liver toxicity).¹⁵ **Why the concern:** Butterbur naturally contains **pyrrolizidine alkaloids (PAs)** — potent liver toxins. While some commercial products (notably Petadolex) undergo purification to remove PAs, cases of serious liver injury — some requiring transplantation — have been reported, and Petadolex has **lost its marketing approval in Germany, Switzerland, and the UK**.¹⁵ **Current guidance:** The NIH National Center for Complementary and Integrative Health advises using butterbur **only if** the product is certified PA-free, and only after consultation with a healthcare provider. Even with PA-free products, long-term safety data are insufficient.¹³ **Bottom line:** Given the availability of safer and highly effective alternatives (CGRP mAbs, other supplements), most current headache specialists **do not recommend** butterbur routinely. ### Vitamin D — Emerging Evidence Vitamin D deficiency is associated with approximately **1.2 times more migraine headache days**, and higher vitamin D levels are associated with reduced migraine risk.¹³ A meta-analysis of 6 RCTs found that vitamin D supplementation decreased the number of headache attacks per month and headache days per month and improved disability scores.¹³ If you have low vitamin D levels (ask your doctor for a blood test), correction with supplementation (typically 2,000 IU/day of vitamin D3) is reasonable and safe. --- ## Other Complementary Approaches ### Biofeedback and Relaxation Therapies Both thermal biofeedback (learning to warm hands, signaling peripheral vasodilation) and EMG biofeedback have Grade A evidence from the AAN/AHS for migraine prevention. These techniques are as effective as drug prevention for some patients and can be combined with medication.⁹ ### Mindfulness and Meditation Mindfulness-Based Stress Reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) are increasingly studied for migraine and have shown benefit for attack frequency, pain intensity, and disability. Mindfulness is especially well-suited for patients with significant stress or anxiety comorbidity. ### Yoga As noted above, yoga was the only exercise intervention in a meta-analysis that significantly reduced both migraine **frequency and intensity**.⁸ Regular yoga practice combines physical movement, breath control, and relaxation — addressing multiple migraine pathways simultaneously. ### Cannabis/Cannabinoids — Emerging and Controversial Preclinical evidence suggests the endocannabinoid system may play a role in migraine modulation, with CB1 receptor agonists potentially suppressing CSD in animal models.² Some patients report benefit. However, **clinical trial evidence in humans remains very limited**, and cannabis use also carries risk of cannabis use disorder, and paradoxically, cannabinoid hyperemesis syndrome with heavy use. This remains an area of active research and is not currently endorsed by headache societies. ### Neuromodulation Devices Several FDA-cleared devices offer non-drug migraine treatment: - **CEFALY** (electrical trigeminal nerve stimulation) — applied to the forehead; effective for both acute and preventive treatment - **Nerivio** (remote electrical neuromodulation, REN) — arm-worn device for acute treatment - **gammaCore Sapphire** (non-invasive vagus nerve stimulation) — effective for episodic cluster headache and some migraine - **sTMS mini** (single-pulse transcranial magnetic stimulation) — FDA-cleared for migraine with aura These devices are particularly useful for patients who prefer medication-free options or who cannot tolerate pharmacological treatment. --- ## When to Seek Emergency Care **Call 911 or go to an emergency room immediately for:** - **Thunderclap headache** — the worst headache of your life, reaching peak intensity within seconds to a minute (may indicate brain aneurysm rupture) - Headache with stiff neck, fever, rash, or confusion (possible meningitis) - Headache after head injury or fall - New headache after age 50 - Headache with vision loss, weakness, numbness, or difficulty speaking (possible stroke — these can also be migraine aura, but must be evaluated urgently) - Headache that is progressively worsening over days to weeks - A severe headache in someone who has never had migraines before --- ## Keeping a Migraine Diary A headache diary is one of the most valuable tools you have. Track: - **Date and time** of headache onset and resolution - **Pain intensity** (1–10 scale) - **Location and character** of pain - **Associated symptoms** (nausea, light/sound sensitivity, aura) - **Possible triggers** (sleep, food, stress, weather, hormonal cycle) - **Medications taken** (what, how much, what time) and their effectiveness - **Missed work or school days** Many smartphone apps (e.g., Migraine Buddy, Headache Coach) can automate tracking and help identify patterns. Share your diary with your healthcare provider at each visit. Tracking also helps identify medication overuse before MOH develops. --- ## Key Takeaways for Living with Migraine 1. **Migraine is a real neurological disease** — not a character flaw or weakness. 2. **CGRP is the central molecular player** — new medications targeting it are transforming treatment. 3. **Lifestyle consistency** (sleep, meals, hydration, exercise) is as important as medication. 4. **Treat attacks early** — waiting makes them harder to stop. 5. **Acute medication limits matter** — staying within safe use thresholds prevents MOH. 6. **Preventive therapy is underused** — if you have frequent migraines, ask about prevention. 7. **Acupuncture is evidence-supported** — a reasonable complementary or alternative option. 8. **Magnesium and riboflavin are safe first-line supplements** to try before other options. 9. **You are not alone** — connect with the American Migraine Foundation (americanmigrainefoundation.org) for resources and support. --- ## References and Citations 1. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. _BMJ_. 1995;311:541–544. https://doi.org/10.1136/bmj.311.7004.541 2. Frimpong-Manson K et al. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. _Frontiers in Molecular Neuroscience_. 2024;17:1355281. https://doi.org/10.3389/fnmol.2024.1355281 3. Francis N. Deciphering the pathophysiology of migraine: Understanding trigeminovascular system activity and the importance of the gut-brain axis. _International Journal of Molecular Biotechnological Research_. 2024;2(1):50–61. https://journals.stmjournals.com/ijmbr/article=2024/view=147948/ 4. Pietrobon D, Moskowitz MA. Pathophysiology of migraine. _Annual Review of Physiology_. 2013;75:365–391. https://www.research.unipd.it/bitstream/11577/2598848/1/annurev-physiolPietrobon-Moskowitz.pdf 5. Casanova A, Vives-Mestres M, Donoghue S, et al. The role of avoiding known triggers, embracing protectors, and adhering to healthy lifestyle recommendations in migraine prophylaxis: Insights from a prospective cohort of 1125 people with episodic migraine. _Headache: The Journal of Head and Face Pain_. 2023;63(1):51–61. https://doi.org/10.1111/head.14451 6. Ailani J, Burch RC, Robbins MS, and the Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. _Headache: The Journal of Head and Face Pain_. 2021;61(7):1021–1039. https://doi.org/10.1111/head.14153 7. Rains JC. Sleep and migraine: Assessment and treatment of comorbid sleep disorders. _Headache: The Journal of Head and Face Pain_. 2018;58(7):1074–1091. https://doi.org/10.1111/head.13357 8. Reina Verona I, et al. (Meta-analysis: exercise interventions for migraine treatment). Summarized in: Nigam M, Cheng N. Essential readings in headache medicine: Top 10 educational articles for trainees from 2022–2024. _Headache: The Journal of Head and Face Pain_. 2025;65(7):1051–1053. https://doi.org/10.1111/head.14967; and: Woldeamanuel YW. Editorial: Rethink your exercise for precision migraine management. _Headache_. 2025;66(1):11–14. https://doi.org/10.1111/head.15077 9. American Headache Society. The American Headache Society Position Statement on Integrating New Migraine Treatments Into Clinical Practice. _Headache: The Journal of Head and Face Pain_. 2018;59(1):1–18. https://doi.org/10.1111/head.13456 10. Migraine Disorders. Addressing Medication Overuse Headache (MOH) in Clinical Practice. American Migraine Foundation. https://www.migrainedisorders.org/medication-overuse-headache-in-clinical-practice/ [Accessed May 2026]; also: ICHD-3 diagnostic criteria; StatPearls. Medication-Overuse Headache. Updated 2023. https://www.ncbi.nlm.nih.gov/books/NBK538150/ 11. Li Y, Xiao X, Zhong D, et al. Effectiveness and safety of acupuncture for migraine: An overview of systematic reviews. _Pain Research and Management_. 2020;2020:3825617. https://doi.org/10.1155/2020/3825617 12. Zhang N, Houle T, Hindiyeh N, Aurora SK. Systematic review: Acupuncture vs standard pharmacological therapy for migraine prevention. _Headache: The Journal of Head and Face Pain_. 2020;60(2):309–317. https://doi.org/10.1111/head.13723 13. Papasavvas T et al. Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur nutraceutical review for migraine prevention. _PubMed_. 2025. PMID: 39853578. https://pubmed.ncbi.nlm.nih.gov/39853578/; and: An Update on Nutraceuticals for Migraine Management. _Practical Neurology_. 2026. https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/ 14. Fasanghari M et al. Bridging Gaps in Migraine Management: A Comprehensive Review. _PMC_. 2025. PMC11858087. https://pmc.ncbi.nlm.nih.gov/articles/PMC11858087/ 15. Butterbur AAN Guideline Retired 2015. Confirmed via: Medical News Today. Butterbur: Benefits, side effects, and risks. https://www.medicalnewstoday.com/articles/319667; and: American Academy of Neurology. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. _Neurology_. 2012;78(17):1346–1353. [RETIRED 2015]. https://doi.org/10.1212/WNL.0b013e3182535d0c 16. Zhang X et al. An overview of systematic reviews of randomized controlled trials on acupuncture treating migraine. _Pain Research and Management_. 2019;2019:5930627. https://doi.org/10.1155/2019/5930627 17. VA/DoD Clinical Practice Guideline for the Management of Headache. _Annals of Internal Medicine_. 2024. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/pain/headache/Headache-CPG-Annals-2024.pdf --- _This patient handout was developed using evidence from peer-reviewed literature, clinical practice guidelines from the American Headache Society (AHS), American Academy of Neurology (AAN), and the U.S. Department of Veterans Affairs/Department of Defense (VA/DoD). Information is current as of May 2026. Always consult your healthcare provider for personalized medical advice._ --- _Scholar Gateway research results retrieved by Scholar Gateway · Summary generated by AI — verify claims against source documents · Last corpus update: February 2026._